Glucagonoma syndrome: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Castro, Pablo ^a   De Leán, Alberto ^a   Trancán, Jose ^a   Martínez, Paloma ^a   Álvarez Pérez, Jose A ^a   Fernández Fernández, Jose C ^a   García Bernardo, Carmen M ^a   Serra, Luis ^a   González González, Juan J ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN; GLUCAGON; HEMOGLOBIN; STEROID; SYNAPTOPHYSIN;

AGED; ANOREXIA; ARTICLE; CANCER PATIENT; CASE REPORT; CELL DEATH; ECZEMA; EPIDERMIS; FEMALE; GLOSSITIS; GLUCAGON BLOOD LEVEL; GLUCAGONOMA; GLUCAGONOMA SYNDROME; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPOALBUMINEMIA; HYPOPROTEINEMIA; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LEG THROMBOSIS; LICHENOID ERUPTION; LYMPH NODE DISSECTION; LYMPHOCYTIC INFILTRATION; MALIGNANT GLUCAGONOMA; MALIGNANT NEOPLASTIC DISEASE; NECROLYTIC MIGRATORY ERYTHEMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS RESECTION; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SKIN BIOPSY; SPLENECTOMY; STEROID THERAPY; STOMATITIS; TRUNK; TUMOR LOCALIZATION; WEIGHT REDUCTION;

EID: 80052701004     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-402     Document Type: Article

References (14)

1. Surgical strategy for large or malignant endocrine pancreatic tumors. Hellman P, Andersson M, Rastad J, Juhlin C, Karacagil S, Eriksson B, Skogseid B, Akerström G, World J Surg 2000 24 1353 1360 10.1007/s002680010224 11038206
2. Glucagonoma diagnosed by arterial stimulation and venous sampling (ASVS). Okauchi Y, Nammo T, Iwahashi H, Kizu T, Hayashi I, Okita K, Yamagata K, Uno S, Katsube F, Matsuhisa M, Kato K, Aozasa K, Kim T, Osuga K, Nakamori S, Tamaki Y, Funahashi T, Miyagawa J, Shimomura I, Inter Med 2009 48 1025 1030 10.2169/internalmedicine.48.1676
3. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Wermers RA, Fatourechi V, Wynne AG, Kvols LK, Lloyd RV, Medicine 1996 75 53 63 10.1097/00005792-199603000-00002 8606627 (Pubitemid 26112227)
4. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Chastain MA, Am J Med Sci 2001 321 306 320 10.1097/00000441- 200105000-00003 11370794 (Pubitemid 32428831)
5. The glucagonoma syndrome: clinical features, diagnosis, and treatment. Stacpoole PW, Endocr Rev 1981 2 347 361 10.1210/edrv-2-3-347 6268399
6. Pancreatic neuroendocrine tumours. O'Grady HL, Conlon KC, Eur J Surg Oncol 2008 34 324 332 17967523 (Pubitemid 351312867)
7. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review. van Beek AP, de Haas ER, van Vloten WA, Lips CJ, Roijers JF, Canninga-van Dijk MR, Eur J Endocrinol 2004 151 531 537 10.1530/eje.0.1510531 15538929 (Pubitemid 39562506)
8. Glucagonoma syndrome and necrolytic migratory erythema. Lobo I, Carvalho A, Amaral C, Machado S, Carvalho R, Int J Dermatol 2010 49 24 29 10.1111/j.1365-4632.2009.04220.x 20465606
9. Necrolytic migratory erythema associated with glucagonoma: a report of 2 cases. Teixeira RC, Nico MM, Ghideti AC, Clinics (Sao Paulo) 2008 63 267 270
10. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT, Arch Surg 2003 138 859 866 10.1001/archsurg.138.8.859 12912744 (Pubitemid 36960947)
11. Pancreatic endocrine tumors. berg K, Semin Oncol 2010 37 594 618 10.1053/j.seminoncol.2010.10.014 21167379
12. Solid pseudopapillary tumors of the pancreas: review of 718 patients reported in English literature. Papavramidis T, Papavramidis S, J Am Coll Surg 2005 100 965 972 (Pubitemid 40744806)
13. Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis. Konukiewitz B, Enosawa T, Klöppel G, Virchows Arch 2011 458 47 53 10.1007/s00428-010-0985-6 20922407
14. Glucagonoma and pseudoglucagonoma syndromes. Schwartz RA, Int J Dermatol 1997 36 81 89 10.1046/j.1365-4362.1997.00042.x 9109001 (Pubitemid 27144221)